Last year's first quarter saw a flurry of biotech takeover deals, starting off with Johnson & Johnson (JNJ)/Ambrx, Merck (MRK)/Harpoon, GSK (GSK)/Aiolos and Novartis(NVS)/Calypso in early January.
It’s anonymous! I’m a 75-year-old male who married the love of my life four years ago. My problem is that for the past two years at least, I’ve had a difficult time coming. I have no trouble getting ...